Komori
Adjuvant Holdings (4929) · RiskRestated

Risks of Intellectual Property Infringement, Counterfeit Products and Conflicts with Third-Party Patents

First written in FY2016. 9 of 10 entries say "Restated". Latest entry: FY2026.

10entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY20262016: 120162017: 120172018: 120182019: 120192020: 220202021: 120212022: 120222023: 120232024: 020242025: 020252026: 12026
Same theme, other companies
Third-Party and Own Intellectual Property Rights Infringement RiskA theme 365 companies write about · 366 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2025: 9 of 59 companies on the "Worse" side.

127 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 200 companies compared. The sentences above are computed from all 200.Comparing 200 of the theme's 366 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026RestatedAnnual report

    「The Group also proceeds with product development while conducting thorough searches of patents, trademarks and other rights. However, it may infringe third-party patents outside the scope of the Group’s awareness, such as when it develops or sells products before another company’s patent application has been published.」

    Reconfirms the risks of intellectual property infringement, imitation products and infringement of third-party patents, as well as the response through patent and trademark searches.
  2. FY2023RestatedAnnual report

    「The Group also proceeds with product development while conducting thorough searches of patents, trademarks and other rights. However, it may infringe third-party patents outside the scope of the Group’s awareness, such as when it develops or sells products before another company’s patent application has been published.」

    Reconfirms the risks of intellectual property infringement, imitation products and infringement of third-party patents, as well as the response through patent and trademark searches.
  3. FY2022RestatedAnnual report

    「The Group also proceeds with product development while conducting thorough searches of patents, trademarks and other rights. However, it may infringe third-party patents outside the scope of the Group’s awareness, such as when it develops or sells products before another company’s patent application has been published.」

    Reconfirms the risks and responses relating to infringement of its own intellectual property, imitation products and infringement of third-party patents.
  4. FY2021-Q3RestatedAnnual report

    「During the cumulative third quarter of the fiscal year under review, there were no newly arising business or other risks. There were also no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    States that there have been no material changes in the risks of intellectual property infringement, imitation products and infringement of third-party patents.
  5. FY2021-Q2RestatedAnnual report

    「During the cumulative consolidated period for the second quarter, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」

    States that there have been no material changes in the risks of intellectual property infringement, imitation products and infringement of third-party patents.
  6. FY2020-Q3RestatedAnnual report

    「During the cumulative third quarter of the fiscal year under review, there were no newly arising business or other risks. There were also no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    States that there have been no material changes in the risks of intellectual property infringement, imitation products and infringement of third-party patents.
  7. FY2019RestatedAnnual report

    「The Group also proceeds with product development while conducting thorough searches of patents, trademarks and other rights. However, it may infringe third-party patents outside the scope of the Group’s awareness, such as when it develops or sells products before another company’s patent application has been published.」

    Reiterates the risks and responses relating to infringement of its own intellectual property, imitation products and infringement of third-party patents.
  8. FY2018RestatedAnnual report

    「The Group also proceeds with product development while conducting thorough searches of patents, trademarks and other rights. However, it may infringe third-party patents outside the scope of the Group’s awareness, such as when it develops or sells products before another company’s patent application has been published.」

    Reiterates the risks and responses relating to infringement of its own intellectual property, imitation products and infringement of third-party patents.
  9. FY2017RestatedAnnual report

    「The Group takes measures to protect its intellectual property rights. However, if its intellectual property rights are infringed through unforeseen means or otherwise, resulting in the leakage of technology or information or imitation products entering the market, this could adversely affect its business activities.」

    Reiterates the risks relating to infringement of its own intellectual property, imitation products and infringement of third-party patents.
  10. FY2016First statedAnnual report

    「The Group takes measures to protect its intellectual property rights. However, if its intellectual property rights are infringed through unforeseen means or otherwise, resulting in the leakage of technology or information or imitation products entering the market, this could adversely affect its business activities.」

    Assumes both infringement of its own rights and infringement of third-party rights.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Adjuvant Holdings's next results are scheduled for 2026-10-21. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Risks of Intellectual Property Infringement, Counterfeit Products and Conflicts with Third-Party Patents | ADJUVANT HOLDINGS CO.,LTD. (4929) | Komori